新生血管抑制剂人纤溶酶原kringle5的研究进展

Studying and progression of human plasminogen kringle 5

  • 摘要: 新生血管对于肿瘤的的生长、浸润和转移具有重要的意义,当瘤体体积超过1~2mm3时就需要新生血管提供营养维持代谢,同时提供转移通路。人纤溶酶原kringle5作为一种血管生成抑制因子,能够与新生血管的内皮细胞特异性结合,通过抑制新生血管内皮细胞增殖而减少新生血管的形成,因此在肿瘤新生血管靶向性治疗中具有很大的应用前景。利用核素标记人纤溶酶原kringle5对多种肿瘤及其转移病灶进行显像的同时实施内照射治疗,这一独特的肿瘤诊疗方法将受到人们的重视。

     

    Abstract: Neovascularization plays an important role in the processes of growth, invasion and metastasis in tumors. Solid tumors rely on neovaseularization to get oxygen and other nutrients supply, otherwise they are not able to expand over 1~2mm3. Meanwhile angiogenesis offers the pathway for metastasis. Hence, inhibitars of angiogenesis become the promise in the therapeutic research. Plasminogen kringle 5 is a proteolytic fragment of plasminogen. Inhibit proliferating vascular endothelial cells but also can induce apoptosis. These results suggest that the anti-angiogenic activity of kringle 5 shows its promising future in cancer therapy. The certain radiopharmaceuticals can be used to perform both imaging and internal radiotherapy in many kinds of carcinomas, in both original and metastatic sites. This unique method will catch our eyes dramatically.

     

/

返回文章
返回